News from Merck
Stay current with all the latest and breaking news about Merck, compare headlines and perspectives between news sources on stories happening today. In total, 70 stories have been published about Merck which Ground News has aggregated in the past 3 months.
Covered Most By
Suggest a source
Looking for a source we don't already have? Suggest one here.Top Merck News
Latest News Stories
Merck · SerbiaRepresentatives of the Government of Serbia and the German company “Merck”, one of the world's leading scientific and technological companies, today signed a Memorandum of UnderstandingSee the Story
Memorandum of the Government of Serbia and the company “Merk” the basis for new innovations and a chance for science
PfizerThe global PCV market, valued at ~$8 billion annually, is poised for significant growth, estimated to reach ~$12 billion soon. Market dynamics are shifting towards adults, potentially doubling with the US discussing vaccination age reduction. Prevnar20 dominates with 97% market share in adults, but Vaxcyte's advanced conjugate capabilities present a competitive advantage.
Latest Ratings for PCVX DateFirmActionFromTo Jul 2020NeedhamInitiates Cov…See the Story
Vaccine Player Vaxcyte Has Advantage Over Pfizer, Merck's Pneumococcal Shots - Analyst Says - Vaxcyte (NASDAQ:PCVX)
100% Center coverage: 1 sources
Cancer · HungaryModerna shares posted an 8% rise after their personalized cancer vaccine, developed in partnership with Merck, showed positive results in an early-stage trial targeting a type of head and neck cancer, giving promising signs to prepare the immune system against cancer cells.See the Story
Vaccine Manufacturer Moderna Announces Super News: Optimism Is Huge
Merck · FranceIvan Donzelot takes a selfie with high school students from Belin, in Vesoul, his former school. Executive Vice President of the Merck scientific group, where he manages 13,000 people, he is offering a grant of €5,000 and the opportunity to visit a site in the US in 2025. Photo Edouard ChouletSee the Story
Vesoul. Head of Merck’s 13,000 employees, he returns to his former high school with a gift and a message
Merck · New JerseySINGAPORE and NORTH BRUNSWICK, N.J. and HANGZHOU, China, March 29, 2024 (GLOBE NEWSWIRE) -- Adlai Nortye Ltd. (NASDAQ:ANL) (the "Company" or "Adlai Nortye"), a clinical-stage biotechnology company focused on the development of innovative cancer therapies, today announced the appointment of Dr. Archie Tse as Head of Research & Development, reporting to Mr. Carsten Lu, CEO and Chairman of Adlai Nortye, effective March 29th, 2024. Dr. Tse, M.D. &…See the Story
Adlai Nortye Announces Appointment of Dr. Archie Tse as the Head of Research & Development - Adlai Nortye (NASDAQ:ANL)
100% Center coverage: 1 sources
MerckOn March 26th, the US FDA granted approval for Merck’s WINREVAIR™ (sotatercept-csrk), marking a significant milestone in pulmonary arterial hypertension (PAH) treatment. PAH, characterized by elevated blood pressure in the arteries connecting the heart and lungs, poses a grave risk of heart failure.See the Story
An ActRIIA fusion protein got FDA approved for PAH treatment
100% Center coverage: 1 sources